scholarly article | Q13442814 |
P50 | author | Iztok Hozo | Q57085272 |
Benjamin Djulbegovic | Q28050789 | ||
P2860 | cites work | At what degree of belief in a research hypothesis is a trial in humans justified? | Q51040935 |
Acceptable regret in medical decision making | Q51084374 | ||
Regret graphs, diagnostic uncertainty and Youden's Index | Q51113974 | ||
Linking evidence-based medicine therapeutic summary measures to clinical decision analysis | Q52083135 | ||
Equation and nomogram for calculation of testing and treatment thresholds | Q52307365 | ||
When (not) to stop a clinical trial for benefit. | Q55041376 | ||
Equipoise, knowledge and ethics in clinical research and practice | Q58673192 | ||
Clinical trials as diagnostic tests. | Q64993019 | ||
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus | Q68122887 | ||
Why most published research findings are false | Q21092395 | ||
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial | Q21144715 | ||
Le Comportement de l'Homme Rationnel devant le Risque: Critique des Postulats et Axiomes de l'Ecole Americaine | Q29038489 | ||
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies | Q29616285 | ||
Contradicted and initially stronger effects in highly cited clinical research | Q29620013 | ||
A proposed charter for clinical trial data monitoring committees: helping them to do their job well | Q33212101 | ||
Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer | Q33810287 | ||
Toward evidence-based medical statistics. 2: The Bayes factor | Q33866194 | ||
Toward evidence-based medical statistics. 1: The P value fallacy | Q33866199 | ||
Better reporting of harms in randomized trials: an extension of the CONSORT statement | Q33983100 | ||
Therapeutic Decision Making: A Cost-Benefit Analysis | Q34082635 | ||
Null results in clinical trials: the need for a decision-theory approach | Q36043832 | ||
Are all significant P values created equal? The analogy between diagnostic tests and clinical research | Q41456025 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e26 | |
P577 | publication date | 2007-02-01 | |
P1433 | published in | PLOS MEDICINE | Q1686921 |
P1476 | title | When should potentially false research findings be considered acceptable? | |
P478 | volume | 4 |
Q33693923 | A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-making |
Q36086675 | Assessing Institutional Ethics Committees in India Using the IRB-RAT. |
Q39020380 | Computational Search for Possible Mechanisms of 4-Thiazolidinones Anticancer Activity: The Power of Visualization |
Q40337089 | Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular disease |
Q34401953 | Dual processing model of medical decision-making |
Q30375899 | Epistemologic inquiries in evidence-based medicine. |
Q37979709 | Evidence-based guideline of the German Nutrition Society: carbohydrate intake and prevention of nutrition-related diseases |
Q97562240 | Evidence-based medicine in times of crisis |
Q34111407 | Extensions to regret-based decision curve analysis: an application to hospice referral for terminal patients |
Q38562652 | Insights from a Personal Journey in field of Orthopaedic Research and Publications |
Q80733897 | Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? |
Q37329334 | Interpretation of tests of heterogeneity and bias in meta-analysis |
Q29032830 | Meta-assessment of bias in science |
Q37247261 | Pharmaco-epistemology for the prescribing geriatrician |
Q42800368 | Stopping guidelines for an effectiveness trial: what should the protocol specify? |
Q38630683 | Talking the talk, but not walking the walk: RT-qPCR as a paradigm for the lack of reproducibility in molecular research |
Q34178142 | The False-positive to False-negative Ratio in Epidemiologic Studies |
Q37641067 | The use of older studies in meta-analyses of medical interventions: a survey. |
Q50752516 | Towards theory integration: Threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory |
Q35242940 | Uncertainty and Equipoise: At Interplay Between Epistemology, Decision Making and Ethics |
Q34778608 | When is diagnostic testing inappropriate or irrational? Acceptable regret approach |
Q38353140 | When is rational to order a diagnostic test, or prescribe treatment: the threshold model as an explanation of practice variation |
Q47843414 | When to perform hepatic resection for intermediate-stage hepatocellular carcinoma |
Q34089254 | Why the need for qPCR publication guidelines?--The case for MIQE. |
Search more.